期刊文献+

CD28单克隆抗体对病毒性心肌炎小鼠的治疗作用

Therapeutic role of the CD28 monoclonal antibody in mice with viral myocarditis
下载PDF
导出
摘要 目的探讨CD28单克隆抗体(CD28 mAb)对柯萨奇病毒B3(CVB3)病毒性心肌炎(VMC)小鼠的死亡率、心肌病理改变及病毒滴度的影响。方法随机将106只BALB/c小鼠分为CD28 mAb组16只、病毒组40只I、gG组40只及正常对照组10只,腹腔注射半数组织感染量(TCID50)为10-6/mL的柯萨奇B3病毒0.15 mL,正常对照组接种0.15 mL的Eagle氏液。CD28 mAb组I、gG组接种病毒后67、2 h分别接种CD28 mAb(0.1 mg/kg)和IgG(0.1 mg/kg)。于接种病毒后第7天处死所有小鼠,取心脏,在光镜下观察心肌病理变化,采用实时荧光定量PCR(RQ-PCR)检测心肌组织中CVB3mRNA的表达。结果CD28单克隆抗体组小鼠死亡率、心肌病理积分、心肌CVB3mRNA均低于病毒对照组(P均<0.05)。结论CD28单克隆抗体可降低心肌病毒滴度,减轻VMC小鼠心肌炎症,降低VMC小鼠死亡率。 Objective To investigate the effect of the CD28 monoclonal antibody (CD28 mAb) on mortality, viral titers of myocardium and pathologic changes of myocardium in CVB3 myocarditis in mice. Methods A total of 106 BALB/c male mice were used in the experiments, which were randomly divided into the CD28 mAb group ( 16 mice), the CVB3 group (40 mice), the IgG group (40 mice) and the control group ( 10 mice). Mice in the former three groups were intraperitoneally inoculated with 0. 15 mL CVB3 (TCIDS0 10-6/mL) and in the control group with 0.15 mL eagle, and then mice in the IgG and the CD28 mAb groups were inoculated with IgG(0.1 mg/kg) and CD28 mAb(0. 1 mg/kg) at 6 hours and 72 hours post-inoculation(p.i. ). The surplus mice in each group were sacrificed on day 7. The heart was taken and pathologic changes of cardiac muscle cells were observed under light microscopy, and expression of CVB3 mRNA of myocardium was determined by the real-time quantitative poly- merase chain reaction(RQ-PCR) method. Results The mice mortality rate in the CD28 mAb group was lower than that in the CVB3 group (80% vs 50%, P 〈 0.05) ; the pathological score(8.88 ± 2.95 vs 5.25 ± 1.91, P 〈 0.05) and the CVB3mRNA expression level(3.48 ± 2.89 vs 0.51 ± 1.80, P 〈 0.05). Conclusion CD28 mAb could decrease the expression of CVB3 mRNA, relieve myocardium inflammation and reduce the mortality rate.
出处 《山东大学学报(医学版)》 CAS 北大核心 2008年第11期1037-1040,共4页 Journal of Shandong University:Health Sciences
关键词 病毒性心肌炎 柯萨奇病毒感染 小鼠 近交BALBC CD28单克隆抗体 Viral myocarditis Coxsaokie virus infection Mice, Inbred BALB C CD28 monoclonal antibody
  • 相关文献

参考文献11

  • 1Liu P, Martino T, Opavsky M A, et al. Viral myocarditis: Balance between viral infection and immune response[J]. Can J Cardiol, 1996, 12(10):935-943.
  • 2姜庆,吴军,易绍萱,陈希炜,罗高兴,贺伟峰.CTLA4Ig诱导免疫耐受的体外研究[J].第三军医大学学报,2003,25(21):1896-1898. 被引量:4
  • 3Batra A S, Lewis A B. Acute myocarditis[J]. Curr Opin Pediatr, 2001, 13(3) :234-239.
  • 4Seko Y, Takahashi N, Ishiyama S. Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy[J]. Circulation, 1998, 97(7) :637-639.
  • 5Seko Y, Takahashi N, Oshima H, et al. Expression of tumour necrosis factor(TNF) receptor/ligand superfamily costimulatory molecules CD40, CD30L, CD27L and OX40L in murine heart with chronic ongoing myocarditis caused by coxsackie virus B3 [J]. J Pathol, 1999, 188(3):423-430.
  • 6Sharpe A H, Freeman G J. The B7-CD28 superfamily[J].Nat Rev Immunol, 2002, 2(2) : 116-126.
  • 7Matsui Y, Inobe M, Okamoto H, et al. Blockade of T cell costimulatory signals using adenovims vectors prevents both the induction and the progression of experimental autoimmune myocarditis[J]. J Mol Cell Cardiol, 2002, 34(3) :279-295.
  • 8刘巍,高成,周保国,王秀荣,李冬梅,李悦,李为民.腺病毒载体介导的共刺激分子融合蛋白对实验性自身免疫性心肌炎的作用[J].中华微生物学和免疫学杂志,2006,26(5):452-457. 被引量:10
  • 9Seko Y, Takahashi N, Azuma M, et al. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3 [ J]. Circ Res, 1998, 82(5) :613-618.
  • 10Seko Y, Takahashi N, Azuma M, et al. Expression of a costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD4OUB7-1 monoclonal antibodies[J]. Cire Res, 1998, 83 (4) :463-469.

二级参考文献21

  • 1蒋毅,万康林,耿震,侯学霞.中国莱姆病伽氏疏螺旋体蛋白免疫印迹法诊断标准的研究[J].中华微生物学和免疫学杂志,2005,25(7):594-598. 被引量:11
  • 2Kishimoto K, Dong V M, Issazadeh S, et al. Tne role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and TH2 responses in vivo[J]. J Clin Invest, 2000, 106(1):63-72.
  • 3Freeman G J, Freeman A S, Sege J M, et al. B7 a new member of the Ig superfamily with unique expression in activated and neoplastic B cells[J]. J Immunol, 1989, 143( 1 ) :2714 - 2721.
  • 4Brunet J F, Denizot F, Luciani M F, et al. A new member of the immunoglobulin superfmnily CTLA4[J]. Nature, 1987, 328(6 127):267-270.
  • 5Mlison J P. CD28-B7 interactions in T-cell activation[J]. Curr Opin Immunol, 1994, 6(3) :414 - 419.
  • 6Hathcock K S, Laszlo G, Dickler H B, et al. Identification of an altematire CTLA4 ligend costimulatory for T cell activation[ J]. Science, 1993,262(5 135) :905 - 907.
  • 7Schwarz A, Beissert S, Grosse-Heitmeyer K, et al. Evidence for functional relevance of CTLA4 in ultraviolet-radiation-induced tolerance[J]. J Immunol, 2000, 165(4) : 1824 - 1831.
  • 8Hale D A, Gottschalk R, Maki T, et al. Use of CTLA4Ig in combination with conventional immunosuppressive agents to prolong allograft survival[ J ].Transplantation, 1997, 64(6) :897 - 900.
  • 9Frauwirth K A, Alegre M L, Thompson C B, et al. Induction of T cell anergy in the absence of CTLA4/B7 interaction[J]. J Immunol, 2000, 164(6) : 2987 - 2993.
  • 10Wingren A G, Parra E, Varga M, et al. T cell activation pathways:B7,LFA-3, and ICAM-lshape unique T cell profiles[J]. Crit Rev Immumol,1995, 15(3-4):235-253.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部